Intracellular Catabolism of an Antibody Drug Conjugate with a Noncleavable Linker
Authors:
- 1 September 2015
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 43 (9) , 1341-1344
Abstract
Antibody drug conjugates are emerging as a powerful class of anti-tumor agents with efficacy across a range of cancers; therefore, understanding the disposition of this class of therapeutic is crucial. Reported here, is a method to enrich a specific organelle (lysosome) to understand the catabolism of an anti-CD70 Ab-MCC-DM1, an antibody drug conjugate with a non-cleavable linker. With such techniques a higher degree of concentration-activity relationship can be established, aiding in dose selection of the antibody drug conjugate.Keywords
This publication has 18 references indexed in Scilit:
- FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast CancerClinical Cancer Research, 2014
- U.S. Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large-Cell LymphomaClinical Cancer Research, 2012
- ADME of Antibody–Maytansinoid ConjugatesThe AAPS Journal, 2012
- The Effect of Different Linkers on Target Cell Catabolism and Pharmacokinetics/Pharmacodynamics of Trastuzumab Maytansinoid ConjugatesMolecular Cancer Therapeutics, 2012
- A novel pathway for maytansinoid release from thioether linked antibody–drug conjugates (ADCs) under oxidative conditionsChemical Communications, 2011
- Antibody–drug conjugates: targeted drug delivery for cancerCurrent Opinion in Chemical Biology, 2010
- Tumor Delivery and In Vivo Processing of Disulfide-Linked and Thioether-Linked Antibody−Maytansinoid ConjugatesBioconjugate Chemistry, 2009
- Antibody-Maytansinoid Conjugates Are Activated in Targeted Cancer Cells by Lysosomal Degradation and Linker-Dependent Intracellular ProcessingCancer Research, 2006
- Enhanced Activity of Monomethylauristatin F through Monoclonal Antibody Delivery: Effects of Linker Technology on Efficacy and ToxicityBioconjugate Chemistry, 2005
- Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells.Proceedings of the National Academy of Sciences, 1988